Showing 341 - 360 of 546 results
Archive
Archive of ANSTO research publications, seminars and short talks.
Food science: Insight into emulsions
Neutron scattering techniques help characterise the structure of a particle based emulsifier
Multiple techniques elucidate hardness with radiation damage
3D models of multilayered structures on engineering scale from nanoscale damage profiles.
Innovative technology provides enhancement to advanced radiation therapy
Neutron Capture Enhanced Particle Therapy developed at ANSTO.
OPAL reactor back in business
Isoscapes of groundwater in NSW will benefit water managers
A large group of ANSTO environmental scientists and collaborators have produced the first groundwater stable isotopes, ‘isoscapes’, intuitive maps with grid data, across NSW combining new and pre-existing isotope measurements.
Supply of nuclear medicine in the news
Lutetium-177 used for advanced prostate cancer
Secondary school tours - Sydney
Come and discover the world of nuclear science at ANSTO - book a school tour in Sydney today.
ANSTO Nuclear Medicine Project
An investment that will secure the long term sustainability of nuclear medicine supply in Australia.
2024 hackathon finalists
Pyrochlore transformation of defect fluorite?
Mathematical insights explain inconsistencies in experimental data: pyrochlore transformation into defect fluorite or not?
Australia’s Nuclear Age Celebrates 70 Years
A day in the life of the OPAL multi-purpose research reactor—Part 3: Evening
Instrument Scientist
Role at ANSTO
National Volunteer Week 2014: Part One
Improving rail transport
Funding awarded for research on an additive manufacturing technique for use on rail infrastructure.
The best behind the neutron beam: Awards announced
Four annual awards in neutron scattering were announced at Australian Neutron Beam Users Group (ANBUG) and AINSE Neutron Scattering Symposium (AANSS) to individuals with strong links to ANSTO
The Australian Synchrotron
A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.
Remarkable clinical trial results shared internationally
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.